Takamaru Ashikaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takamaru Ashikaga has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Donald L. Weaver
University of Vermont
3 shared publications - David N. Krag
University of Vermont Larner College of Medicine
2 shared publications - Seth P. Harlow
University of Vermont
2 shared publications - Alan Stockdale
Education Development Center, Inc., Newton Massachusetts, 02458, USA
1 shared publication Ann M. Brown
Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
1 shared publication- Barbara G. Beatty
Department of Pathology, University of Vermont, Burlington, Vermont
1 shared publication
Latest Publications
- 1 March 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (9) , 2664-2679
Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration
- 1 March 2014
- Published by Elsevier in Biomaterials
- Vol. 35 (9) , 2664-2679
Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration
- Open Access
- 14 July 2010
- Published by Wiley in Journal of Surgical Oncology
- Vol. 102 (2) , 111-118
Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection
Background and Objectives: Three year post‐surgical morbidity levels were compared between patients with negative sentinel lymph node dissection alone (SLND) and those with negative sentinel node dissection and negative axillary lymph node dissection (ALND) in the NSABP B‐32 trial.Methods: A total of 1,975 ALND and 2,008 SLND node negative breast cancer patients had shoulder range of motion and arm volumes assessed along with self reports of arm tingling and numbness. Relative shoulder abduction deficits and relative arm volume differences between ipsilateral and contralateral arms were calculated.Results: Shoulder abduction deficits ≥10% peaked at 1 week for the ALND (75%) and SLND (41%) groups. Arm volume differences ≥10% at 36 months were evident for the ALND (14%) and SLND (8%) groups. Numbness and tingling peaked at 6 months for the ALND (49%, 23%) and SLND (15%, 10%) groups. Logistic regression correlates of residual morbidity included treatment group, age, handedness, tumor size, systemic chemotherapy, and radiation to the axilla.Conclusions: Although residual morbidity for both treatment groups was evident, the results of the NSABP B‐32 study indicate the superiority of the SLND compared to the ALND treatment approach relative to post‐surgical morbidity outcomes over a 3‐year follow‐up period. J. Surg. Oncol. 2010;102:111–118.
- 14 July 2010
- Published by Wiley in Journal of Surgical Oncology
- Vol. 102 (2) , 111-118
Open AccessMorbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection
Background and Objectives: Three year post‐surgical morbidity levels were compared between patients with negative sentinel lymph node dissection alone (SLND) and those with negative sentinel node dissection and negative axillary lymph node dissection (ALND) in the NSABP B‐32 trial.Methods: A total of 1,975 ALND and 2,008 SLND node negative breast cancer patients had shoulder range of motion and arm volumes assessed along with self reports of arm tingling and numbness. Relative shoulder abduction deficits and relative arm volume differences between ipsilateral and contralateral arms were calculated.Results: Shoulder abduction deficits ≥10% peaked at 1 week for the ALND (75%) and SLND (41%) groups. Arm volume differences ≥10% at 36 months were evident for the ALND (14%) and SLND (8%) groups. Numbness and tingling peaked at 6 months for the ALND (49%, 23%) and SLND (15%, 10%) groups. Logistic regression correlates of residual morbidity included treatment group, age, handedness, tumor size, systemic chemotherapy, and radiation to the axilla.Conclusions: Although residual morbidity for both treatment groups was evident, the results of the NSABP B‐32 study indicate the superiority of the SLND compared to the ALND treatment approach relative to post‐surgical morbidity outcomes over a 3‐year follow‐up period. J. Surg. Oncol. 2010;102:111–118.
- Open Access
- 3 June 2010
- Published by Springer Nature in BMC Family Practice
- Vol. 11 (1) , 45
Primary care physicians' use of family history for cancer risk assessment
Background: Family history (FH) assessment is useful in identifying and managing patients at increased risk for cancer. This study assessed reported FH quality and associations with physician perceptions. Methods: Primary care physicians practicing in two northeastern U.S. states were surveyed (n = 880; 70% response rate). Outcome measures of FH quality were extent of FH taken and ascertaining age at cancer diagnosis for affected family members. Predictors of quality measured in this survey included: perceived advantages and disadvantages of collecting FH information, knowledge of management options, access to supportive resources, and confidence in ability to interpret FH. Results: Reported collection of information regarding second degree blood relatives and age of diagnosis among affected relatives was low. All hypothesized predictors were associated with measures of FH quality, but not all were consistent independent predictors. Perceived advantages of taking a family history, access to supportive resources, and confidence in ability to identify and manage higher risk patients were independent predictors of both FH quality measures. Perceived disadvantages of taking a family history was independently associated one measure of FH quality. Knowledge of management options was not independently associated with either quality measure. Conclusions: Modifiable perception and resource factors were independently associated with quality of FH taking in a large and diverse sample of primary care physicians. Improving FH quality for identification of high risk individuals will require multi-faceted interventions.
- 3 June 2010
- Published by Springer Nature in BMC Family Practice
- Vol. 11 (1) , 45
Open AccessPrimary care physicians' use of family history for cancer risk assessment
Background: Family history (FH) assessment is useful in identifying and managing patients at increased risk for cancer. This study assessed reported FH quality and associations with physician perceptions. Methods: Primary care physicians practicing in two northeastern U.S. states were surveyed (n = 880; 70% response rate). Outcome measures of FH quality were extent of FH taken and ascertaining age at cancer diagnosis for affected family members. Predictors of quality measured in this survey included: perceived advantages and disadvantages of collecting FH information, knowledge of management options, access to supportive resources, and confidence in ability to interpret FH. Results: Reported collection of information regarding second degree blood relatives and age of diagnosis among affected relatives was low. All hypothesized predictors were associated with measures of FH quality, but not all were consistent independent predictors. Perceived advantages of taking a family history, access to supportive resources, and confidence in ability to identify and manage higher risk patients were independent predictors of both FH quality measures. Perceived disadvantages of taking a family history was independently associated one measure of FH quality. Knowledge of management options was not independently associated with either quality measure. Conclusions: Modifiable perception and resource factors were independently associated with quality of FH taking in a large and diverse sample of primary care physicians. Improving FH quality for identification of high risk individuals will require multi-faceted interventions.
- 1 September 2005
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 3 (3) , 147-155
Texture Analysis of Post Breast Cancer Lymphedema Ultrasound Images Obtained Using a Portable Device—A Pilot Study
Lymphedema is a common complaint of post-breast cancer treatment. Some prior ultrasound imaging studies of lymphedema-affected upper extremities focused upon estimating the thickness of the dermis and subcutis areas. In contrast, however, the reliability and validity of texture features derived from ultrasound images obtained using a low-cost portable ultrasound device have not been reported. This study examined the reliability and validity of the first and second order quantitative image texture measures, average pixel intensity and entropy, and compared their site-specific correlations. A total of 10 ultrasound images of an ipsilateral affected elbow and the corresponding unaffected contralateral elbow were obtained using a portable ultrasound device. A Graphical User Interface software package for image analysis was developed and tested. Entropy and average pixel intensity at six adjacent regions of interest corresponding to the dermis and subcutis areas were calculated. Entropy had smaller coefficients of variation for each image compared to average pixel intensity with the intracluster correlation reliability coefficient for entropy being twice that of average pixel intensity. Both measures discriminated between the affected and unaffected sites (p < 0.001). However, the correlation between the two measures differed for affected (r = -0.060, p = 0.667) and unaffected (r = +0.595, p < 0.001) sites. The second order measure entropy is preferable to that of the first order average pixel intensity as a measure of image texture to characterize ultrasound images of extremity lymphedema.
- 1 September 2005
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 3 (3) , 147-155
Texture Analysis of Post Breast Cancer Lymphedema Ultrasound Images Obtained Using a Portable Device—A Pilot Study
Lymphedema is a common complaint of post-breast cancer treatment. Some prior ultrasound imaging studies of lymphedema-affected upper extremities focused upon estimating the thickness of the dermis and subcutis areas. In contrast, however, the reliability and validity of texture features derived from ultrasound images obtained using a low-cost portable ultrasound device have not been reported. This study examined the reliability and validity of the first and second order quantitative image texture measures, average pixel intensity and entropy, and compared their site-specific correlations. A total of 10 ultrasound images of an ipsilateral affected elbow and the corresponding unaffected contralateral elbow were obtained using a portable ultrasound device. A Graphical User Interface software package for image analysis was developed and tested. Entropy and average pixel intensity at six adjacent regions of interest corresponding to the dermis and subcutis areas were calculated. Entropy had smaller coefficients of variation for each image compared to average pixel intensity with the intracluster correlation reliability coefficient for entropy being twice that of average pixel intensity. Both measures discriminated between the affected and unaffected sites (p < 0.001). However, the correlation between the two measures differed for affected (r = -0.060, p = 0.667) and unaffected (r = +0.595, p < 0.001) sites. The second order measure entropy is preferable to that of the first order average pixel intensity as a measure of image texture to characterize ultrasound images of extremity lymphedema.
- 1 August 2004
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 122 (2) , 246-255
HER-2/neu Detection in Fine-Needle Aspirates of Breast Cancer Fluorescence In Situ Hybridization and Immunocytochemical Analysis
- 1 August 2004
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 122 (2) , 246-255
HER-2/neu Detection in Fine-Needle Aspirates of Breast Cancer Fluorescence In Situ Hybridization and Immunocytochemical Analysis
- 1 March 1998
- Published by Hindawi Limited in The Breast Journal
- Vol. 4 (2) , 67-74
Development of Sentinel Node Targeting Technique in Breast Cancer Patients
- 1 March 1998
- Published by Hindawi Limited in The Breast Journal
- Vol. 4 (2) , 67-74
Development of Sentinel Node Targeting Technique in Breast Cancer Patients